BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30036223)

  • 41. Predictors of Survival After Recurrence in Women With Early-Stage Endometrial Carcinoma.
    Xu Y; Burmeister C; Hanna RK; Munkarah A; Elshaikh MA
    Int J Gynecol Cancer; 2016 Jul; 26(6):1137-42. PubMed ID: 27206283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium: a collaborative study.
    Vandenput I; Trovik J; Vergote I; Moerman P; Leunen K; Berteloot P; Neven P; Salvesen H; Amant F
    Int J Gynecol Cancer; 2011 Feb; 21(2):332-6. PubMed ID: 21270614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Locally recurrent endometrial cancer: a case report.
    Tantravahi SK; Werner TL
    J Natl Compr Canc Netw; 2012 Apr; 10(4):442-5. PubMed ID: 22491044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interval between hysterectomy and start of radiation treatment is predictive of recurrence in patients with endometrial carcinoma.
    Cattaneo R; Hanna RK; Jacobsen G; Elshaikh MA
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):866-71. PubMed ID: 24444758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors related to recurrent endometrial carcinoma following initial surgery.
    Vavra N; Denison U; Kucera H; Barrada M; Kurz C; Salzer H; Sevelda P
    Acta Obstet Gynecol Scand; 1993 Apr; 72(3):205-9. PubMed ID: 8385857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
    Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
    Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study.
    Kim M; Choi C; Kim K; Lim MC; Park JY; Hong JH; Lee M; Paek J; Seoung J; Lee S; Lee TS
    Int J Gynecol Cancer; 2018 Jul; 28(6):1123-1129. PubMed ID: 29664841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
    Elshaikh MA; Vance S; Suri JS; Mahan M; Munkarah A
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):351-6. PubMed ID: 24411608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Impact of surgical resection extent on the prognosis of clinical stage I endometrial carcinoma].
    Yan X; Gao YN; Jiang GQ; Gao M; An N
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):208-12. PubMed ID: 19615262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.
    Topfedaisi Ozkan N; Meydanlı MM; Sarı ME; Demirkiran F; Kahramanoglu I; Bese T; Arvas M; Şahin H; Haberal A; Celik H; Coban G; Oge T; Yalcin OT; Akbayır Ö; Erdem B; Numanoğlu C; Özgül N; Boyraz G; Salman MC; Yüce K; Dede M; Yenen MC; Taşkın S; Altın D; Ortaç UF; Aydın Ayık H; Şimşek T; Güngör T; Güngördük K; Sancı M; Ayhan A
    J Gynecol Oncol; 2017 Sep; 28(5):e65. PubMed ID: 28657226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis.
    Carrara L; Gadducci A; Landoni F; Maggino T; Scambia G; Galletto L; Lissoni AA; Fuso L; Zola P; Sartori E
    Int J Gynecol Cancer; 2012 Jul; 22(6):1013-9. PubMed ID: 22706226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
    Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Proposal for a Classification for Recurrent Endometrial Cancer: Analysis of a French Multicenter Database From the FRANCOGYN Study Group.
    Bricou A; Bendifallah S; Daix-Moreux M; Ouldamer L; Lavoue V; Benbara A; Huchon C; Canlorbe G; Raimond E; Coutant C; Graesslin O; Collinet P; Carcopino X; Touboul C; Daraï E; Carbillon L; Ballester M;
    Int J Gynecol Cancer; 2018 Sep; 28(7):1278-1284. PubMed ID: 29994907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stage 1C grade 3 endometrial cancer: the KK Hospital gynaecological oncology group experience.
    Siow TR; Yeo MC; Khoo-Tan HS; Yap SP; Soong YL; Chua EJ; Soh LT; Lim YK; Chia YN; Yam KL
    Int J Gynecol Cancer; 2010 Dec; 20(9):1557-62. PubMed ID: 21119369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
    Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
    Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conservative management of stage I endometrial carcinoma after surgical staging.
    Straughn JM; Huh WK; Kelly FJ; Leath CA; Kleinberg MJ; Hyde J; Numnum TM; Zhang Y; Soong SJ; Austin JM; Partridge EE; Kilgore LC; Alvarez RD
    Gynecol Oncol; 2002 Feb; 84(2):194-200. PubMed ID: 11812074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma.
    Cannon GM; Geye H; Terakedis BE; Kushner DM; Connor JP; Hartenbach EM; Bradley KA
    Gynecol Oncol; 2009 May; 113(2):176-80. PubMed ID: 19217147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
    Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
    Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.